Recombinant F11 (Abelacimab Biosimilar) antibody

Catalog No. ABIN7597485

This Human Monoclonal antibody specifically detects F11 (Abelacimab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant F11 (Abelacimab Biosimilar) antibody (ABIN7597485)

Target: F11 (Abelacimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This F11 (Abelacimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-F11 (Abelacimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Abelacimab Biosimilar Antibody

Specificity: Plasma thromboplastin antecedent, PTA, Coagulation factor XI, F11, FXI

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 lambda

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.47 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for F11 (Abelacimab Biosimilar)

Target: F11 (Abelacimab Biosimilar)

Alternative Name: Abelacimab Biosimilar

Target Type: Biosimilar

Background: Plasma thromboplastin antecedent, PTA, Coagulation factor XI, F11, FXI

UniProt: P03951

CAS-No: 2098724-83-3